449
panel
Letting Smiles Shine: Oral Health as the Gateway to Health Equity
While COVID masks have hidden smiles over the past few years, teeth continue to tell a compellin
g story of overall health and wellbeing.
+ Read More
panel
Part 2: The Future of the mRNA Revolution
Messenger RNA, or mRNA, has been a focus of research for scientists and drug developers for many
years.
+ Read More
panel
Time=Lives and Overcoming Challenges to Drug Repurposing
New drugs can take more than a decade to develop and get to market.
panel
Partnering for Pandemic Prevention and Preparedness (Invite only)
The COVID-19 pandemic has spurred significant public investment in tools and resources to predic
t and prepare for future pandemics. Prioritizing and coordinating these investments will be essential to maximize impact and minimize redundancies.
+ Read More
panel
Improving Health Equity in Rare Diseases Research
People with rare diseases face many barriers and inequities in accessing diagnosis, treatment, a
nd comprehensive care. This burden is even greater among marginalized communities with rare diseases.
+ Read More
panel
Building a Diverse and Equitable Health Workforce to Increase Trust in Medical Research and Health Care
To promote health equity within the biomedical research and health-care systems, we must focus o
n having a culturally competent and diverse workforce.
+ Read More
panel
Accelerating Progress for Chronic Disease through Policymaking and Investments (Invite only)
Over half (six in ten) Americans live with a chronic disease, and four in ten live with at least
two. Obesity, diabetes, hypertension, and hypercholesterolemia are common in US.
+ Read More
panel
Future of Health Summit Dinner | A Commitment to Accelerating Cures: The Future of Biomedical Innovation
The new year will begin with fresh leadership at several of the nation's top scientific agencies
. Hear from Dr. Bertagnolli and Dr.
+ Read More
panel
Maximizing the Potential of the New Advanced Research Projects Agency for Health (ARPA-H)
This session will open with a conversation with Representative Anna Eshoo, followed by a panel d
iscussion on ARPA-H.
+ Read More
panel
Time=Lives and What's Next for Patient Engagement: Policymaking as a Driver of Progress
This session will open with a Time=Lives Talk by Sandra Abrevaya and Brian Wallach, Co-Founders
of I AM ALS, followed by a panel discussion on Policymaking as a Driver of Progress.
+ Read More
panel
Part 2: Defining Moments in Health: Leading Through Turbulent Times
The past two years have been marked by moments that define a generation—the COVID-19 pandemic, s
upply chain breakdowns, a shift in American political power, unprecedented social movements,
+ Read More